Sancilio Pharmaceuticals
Riviera Beach, US · Founded 2015 · Delaware corporation
Find your way into Sancilio Pharmaceuticals
40 people in our graph share verified history with the Sancilio Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Philip Youngunlockedknows Frederick Sancilio · together at Lobe Sciences Ltd. (overlapped)
×2knows the team · via Averion International
×2knows the team · via Burroughs Wellcome Company
×3knows the team · via AAIPharma
×4knows the team · via Florida Atlantic University
Founders & leadership
Sancilio Pharmaceuticals was founded in 2015 by Frederick Sancilio.
FS

Frederick SancilioFounderFrederick Sancilio is Chairman and CEO of Lobe Sciences Ltd., a neurology-focused biotechnology company, and President of Clearway Global LLC, a consulting firm advising biopharma startups on research, funding, and regulatory strategy. He is also a Research Professor at Florida Atlantic University and has spent five decades founding and leading several pharmaceutical companies, including Sancilio & Company, aaiPharma (now Alcami), and Aesgen (acquired by Pfizer).
TT
Thorsteinn ThorsteinssonExecutive
TL
Tony LodovicoExecutive
AC
Albert CavagnaroExecutive
GG
Geoffrey GlassExecutive
MW
Marc WolffExecutive
LM
Leandra MollanazarExecutive
Board
JG
Jim GaleBoard director
JC
John CelentanoBoard director
DL
Dennis LangerBoard director
PG
Patrick GrayBoard director
OG
Oscar GroetBoard director
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2018
▶$5MraisedJan 2018 · 7 investors · PharmaceuticalsRule 506(b)
▶$5MraisedJan 2018 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thorsteinn ThorsteinssonExecutive Officer
- Tony LodovicoExecutive Officer
- John CelentanoDirector
- Frederick SancilioDirector
- Dennis LangerDirector
- Albert CavagnaroExecutive Officer
- Geoffrey GlassExecutive Officer, Director
- Jim GaleDirector
- Patrick GrayDirector
- Oscar GroetDirector
- Marc WolffExecutive Officer
- Leandra MollanazarExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $5M
- Minimum investment
- $192.5K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Sancilio Pharmaceuticals?
- Sancilio Pharmaceuticals was founded by Frederick Sancilio in 2015.
- How much funding has Sancilio Pharmaceuticals raised?
- Sancilio Pharmaceuticals has disclosed $5M raised across 1 round.
- Where is Sancilio Pharmaceuticals headquartered?
- Sancilio Pharmaceuticals is headquartered in Riviera Beach, US.